Home
Saba Capital Management reported a 10.33% stake in abrdn Life Sciences Investors HQL · 2,982,706 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 10.33%
- Last report
- 11.36% · filed 25/04/01
- Shares held
- 2,982,706 sh
- Class
- Common Shares, $0.01 par value
- Holder
- Saba Capital Management
- Event date
- 25/08/29
- Filed
- 25/09/03
10.33% stake · −1.0pp from the last report
- Stake
- 10.33%
- Last report
- 11.36%
- Since last report
- −1.0pp
abrdn Life Sciences Investors trades, last 26 weeks
What else happened in abrdn Life Sciences Investors around then
Filed or reported within 30 days of the trade day · 25/07/30~25/09/28Saba Capital Management's other 5% stake reports
- Saba Capital Management
5% stakeVirtus Total Return Fund
5% stakeVirtus Total Return Fund
ZTR
5.04% stake
2,519,703 sh
5.04% stake
Filed 09/30
- Saba Capital Management
5% stakeJapan Smaller Capitalization Fund
5% stakeJapan Smaller Capitalization Fund
JOF
8.8% stake
2,494,542 sh
8.8% stake
Filed 09/23
- Saba Capital Management
5% stakeBlackRock ESG Capital Allocation Term Trust
5% stakeBlackRock ESG Capital Allocation Term Trust
ECAT
12.66% stake
12,588,023 sh
12.66% stake
Filed 09/21
- Saba Capital Management
5% stakeBlackRock ESG Capital Allocation Term Trust
5% stakeBlackRock ESG Capital Allocation Term Trust
ECAT
13.67% stake
13,593,042 sh
13.67% stake
Filed 09/02
- Saba Capital Management
5% stakeJapan Smaller Capitalization Fund
5% stakeJapan Smaller Capitalization Fund
JOF
7.73% stake
2,190,551 sh
7.73% stake
Filed 08/31
